DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Assessment of Interactions Between Methamphetamine and Aripiprazole - 1

Information source: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Amphetamine-Related Disorders

Intervention: Aripiprazole (Drug)

Phase: Phase 1

Status: Active, not recruiting

Sponsored by: National Institute on Drug Abuse (NIDA)

Official(s) and/or principal investigator(s):
Thomas Newton, M.D., Principal Investigator, Affiliation: University of California, Los Angeles


The purpose of this study is to assess the interactions between intravenous methamphetamine and aripiprazole.

Clinical Details

Official title: Assessment of Interactions Between IV Methamphetamine and Aripiprazole

Study design: Primary Purpose: Treatment

Primary outcome:

Adverse effect measures

pharmacokinetic assessment

Detailed description: This is a double-blind, placebo-controlled human laboratory clinical pharmacology study to assess potential interactions between intravenous d-methamphetamine infusion and treatment with oral aripiprazole.


Minimum age: 18 Years. Maximum age: 45 Years. Gender(s): Both.


Inclusion Criteria:

- Must meet DSM-4 criteria for methamphetamine abuse or dependence and are

non-treatment seeking.

- Ability to verbalize understanding of the consent form, able to provide written

informed consent, and verbalize willingness to complete study procedures. Exclusion Criteria:

- Please contact the site for more information.

Locations and Contacts

UCLA Integrated Substance Abuse Program, Los Angeles, California 90024, United States

New York University, School of Medicine, New York, New York 10016, United States

Additional Information

Starting date: June 2004
Last updated: October 25, 2007

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017